Correction: Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study) (Implementation Science Communications, (2025), 7, 1, (10), 10.1186/s43058-025-00837-3)

In this article the Competing interests statement was incorrectly given as NK reports investigator-initiated studies from ViiV Healthcare, Abbvie, and Gilead, and honoraria from Abbvie, all outside this work. JB reports investigator-initiated studies from Gilead, and honoraria from Gilead and Abbvie, all outside this work. JG has received research grants, speaker fees, and participated on advisory boards for AbbVie, Abbott, bioLytical, Cepheid, Gilead Sciences, Hologic, and Roche. GF reports speaker fees/hospitality from Gilead and Abbvie, all outside this work but should have been NK reports investigator-initiated studies from ViiV Healthcare, Abbvie, and Gilead, and honoraria from Abbvie, all outside this work. JB reports investigator-initiated studies from Gilead, and honoraria from Gilead and Abbvie, all outside this work. JG has received research grants, speaker fees, and participated on advisory boards for AbbVie, Abbott, bioLytical, Cepheid, Gilead Sciences, Hologic, and Roche. GF reports speaker fees/hospitality from Gilead and Abbvie, all outside this work and is an Associate Editor of Implementation Science Communications. The original article has been corrected.